Dyfyniad APA

Lundkvist, P., Sjöström, C. D., Amini, S., Pereira, M. J., Johnsson, E., & Eriksson, J. W. (2016). Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Diabetes Obes Metab.

Dyfyniad Arddull Chicago

Lundkvist, Per, C. David Sjöström, Sam Amini, Maria J. Pereira, Eva Johnsson, and Jan W. Eriksson. "Dapagliflozin Once‐daily and Exenatide Once‐weekly Dual Therapy: A 24‐week Randomized, Placebo‐controlled, Phase II Study Examining Effects On Body Weight and Prediabetes in Obese Adults Without Diabetes." Diabetes Obes Metab 2016.

Dyfyniad MLA

Lundkvist, Per, et al. "Dapagliflozin Once‐daily and Exenatide Once‐weekly Dual Therapy: A 24‐week Randomized, Placebo‐controlled, Phase II Study Examining Effects On Body Weight and Prediabetes in Obese Adults Without Diabetes." Diabetes Obes Metab 2016.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.